About
Vortex Biosciences develops and sells the automated VTX-1 benchtop liquid biopsy system that isolates intact circulating tumour cells (CTCs) from whole blood using microscale vortices based on size and deformability for research and clinical applications.
Explore Vortex Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.